Amedisys Valuation
| AMED Stock | USD 90.96 0.29 0.32% |
At this time, the firm appears to be fairly valued. Amedisys shows a prevailing Real Value of $94.06 per share. The current price of the firm is $90.96. Our model approximates the value of Amedisys from analyzing the firm fundamentals such as return on equity of -0.0098, and Profit Margin of (0) % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor purchasing undervalued instruments and exiting overvalued instruments since, at some point, asset prices and their ongoing real values will blend. Key fundamental drivers impacting Amedisys' valuation include:
Price Book 2.8149 | Enterprise Value 3.4 B | Enterprise Value Ebitda 26.1218 | Price Sales 1.3424 | Forward PE 20.284 |
Fairly Valued
Today
Please note that Amedisys' price fluctuation is very steady at this time. Calculation of the real value of Amedisys is based on 3 months time horizon. Increasing Amedisys' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Amedisys is useful when determining the fair value of the Amedisys stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Amedisys. Since Amedisys is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Amedisys Stock. However, Amedisys' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 90.96 | Real 94.06 | Target 96.1 | Hype 90.91 | Naive 90.46 |
The real value of Amedisys Stock, also known as its intrinsic value, is the underlying worth of Amedisys Company, which is reflected in its stock price. It is based on Amedisys' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Amedisys' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Amedisys' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Amedisys helps investors to forecast how Amedisys stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Amedisys more accurately as focusing exclusively on Amedisys' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Amedisys' intrinsic value based on its ongoing forecasts of Amedisys' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Amedisys' closest peers. When choosing an evaluation method for Amedisys, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Amedisys Investments |
|
Amedisys Valuation Trend
Knowing Amedisys' actual value is paramount for traders to make sound investment determinations. Amedisys' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Amedisys' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Amedisys' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Amedisys Market Cap
Amedisys is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is presently estimated at about 34.71 Billion. Amedisys holds roughly 2.99 Billion in market capitalization claiming about 9% of equities under Health Care industry.Amedisys Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Amedisys's current stock value. Our valuation model uses many indicators to compare Amedisys value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amedisys competition to find correlations between indicators driving Amedisys's intrinsic value. More Info.Amedisys is rated below average in price to earning category among related companies. It is rated fifth in price to book category among related companies fabricating about 0.19 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Amedisys is roughly 5.34 . As of April 18, 2024, Price To Book Ratio is expected to decline to 2.57. Comparative valuation analysis is a catch-all model that can be used if you cannot value Amedisys by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amedisys' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amedisys' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Amedisys' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Amedisys and how it compares across the competition.
About Amedisys Valuation
The stock valuation mechanism determines the current worth of Amedisys on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Amedisys. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Amedisys based exclusively on its fundamental and basic technical indicators. By analyzing Amedisys's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Amedisys's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Amedisys. We calculate exposure to Amedisys's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Amedisys's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 457.1 M | 447.4 M | |
| Pretax Profit Margin | 0.02 | 0.02 | |
| Operating Profit Margin | 0.09 | 0.09 | |
| Net Loss | (0) | (0) | |
| Gross Profit Margin | 0.20 | 0.19 |
8 Steps to conduct Amedisys' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Amedisys' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Amedisys' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Amedisys' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Amedisys' revenue streams: Identify Amedisys' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Amedisys' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Amedisys' growth potential: Evaluate Amedisys' management, business model, and growth potential.
- Determine Amedisys' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Amedisys' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Amedisys Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Amedisys does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 32.6 M | |
| Quarterly Earnings Growth Y O Y | -0.397 | |
| Forward Price Earnings | 20.284 |
Amedisys Current Valuation Indicators
Valuation refers to the process of determining the present value of Amedisys and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Amedisys we look at many different elements of the entity such as Amedisys's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Amedisys' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Amedisys' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Amedisys, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Amedisys' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Amedisys' worth.When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amedisys. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.Note that the Amedisys information on this page should be used as a complementary analysis to other Amedisys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Amedisys Stock analysis
When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Amedisys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.40) | Earnings Share (0.30) | Revenue Per Share 68.603 | Quarterly Revenue Growth 0.016 | Return On Assets 0.0598 |
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.